Citation

Titcomb C, Braun R, Roudebush BT, Mast J, Woodman H. J. Insur. Med. 2001; 33(3): 277-289.

Affiliation

cptitcomb@lnc.com

Copyright

(Copyright © 2001, American Academy of Insurance Medicine)

DOI

unavailable

PMID

11558411

Abstract

Evaluation of applicants for life insurance who have elevations of their liver function tests or an increased probability of alcohol abuse has always been difficult for underwriters. This paper reports the results of an intercompany study in which the pooled mortality experience of a group of insureds with evidence of alcohol abuse, an adverse driving record or elevations of the liver transaminases or gamma-glutamyl transferase is summarized.

Language: en